Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 1.99% | 156.12 | 0.7% | $1151.45m | |
| PFE | Pfizer Inc. | 0.50% | 34.37 | 0.9% | $1063.61m | |
| MRK | Merck & Co., Inc. | 1.34% | 73.14 | 0.7% | $859.53m | |
| BMY | Bristol-Myers Squibb Co. | 1.75% | 60.38 | 1.0% | $833.94m | |
| ABBV | AbbVie, Inc. | 0.99% | 106.70 | 1.9% | $716.41m | |
| LLY | Eli Lilly & Co. | 3.13% | 206.81 | 1.1% | $635.54m | |
| AZN | AstraZeneca Plc | 1.76% | 48.06 | 1.2% | $486.33m | |
| GSK | GlaxoSmithKline Plc | 1.84% | 34.91 | 0.2% | $272.42m | |
| NVS | Novartis AG | 0.64% | 84.03 | 0.2% | $166.37m | |
| SNY | Sanofi | 1.50% | 46.59 | 0.2% | $163.16m | |
| VTRS | Viatris, Inc. | 2.36% | 13.91 | 0.0% | $134.52m | |
| VERU | Veru, Inc. | 1.15% | 12.33 | 0.0% | $121.05m | |
| KALV | KalVista Pharmaceuticals, Inc. | -2.16% | 30.88 | 0.4% | $99.62m | |
| NVO | Novo Nordisk A/S | 0.58% | 69.62 | 0.1% | $91.37m | |
| CVAC | CureVac NV | 1.67% | 82.69 | 0.0% | $80.07m |
Company Profile
The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007.